Showing results (1-10 of 210,144) with videos related to

Sort By:
Pageof 21,015
Breast Cancer (Tokyo, Japan)|November 25, 2000
MDM2 in Breast CancerToi, Saji, Suzuki, et al.
Japanese Journal of Cancer Research : Gann|April 21, 1998
Role of MDM2 overexpression in doxorubicin resistance of breast carcinomaA Suzuki, M Toi, Y Yamamoto, et al.
Oncology Reports|May 19, 2011
The increase of apoptosis and the decrease of proliferation by angiogenesis inhibitor in rat mammary tumorsS Saji, M Toi, Y Yamamoto, et al.
Nihon Geka Gakkai Zasshi|May 1, 1996
[The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer]S Saji, M Toi, T Tominaga
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1996
Regulation of endothelial growth factor expressions in breast cancerM Toi, Y Yamamoto, T Taniguchi, et al.
Frontiers in Oncology|October 13, 2012
Impact of body mass index on breast cancer in accordance with the life-stage of womenReiko Suzuki, Shigehira Saji, Masakazu Toi
Oncology Reports|May 20, 2011
Prediction of the effect of 5'-deoxy-5-fluorouridine by the status of angiogenic enzyme thymidine phosphorylase expression in recurrent breast cancer patientsY Yamamoto, M Toi, T Tominaga
Oncology Reports|May 20, 2011
Immunocytochemical analysis of MDM2 protein expression and its relevance to tumor angiogenesis in primary breast cancerK Inada, M Toi, Y Yamamoto, et al.
Oncology Reports|May 21, 2011
Combination effect of an angiogenesis inhibitor agm-1470 with 5'-deoxy-5-fluorouridine, and with hormonal drugs in dmba-induced rat mammary-tumorsY Yamamoto, M Toi, R Yamada, et al.
Breast Cancer Research and Treatment|January 1, 1995
Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expressionM Toi, K Inada, H Suzuki, et al.
Pageof 21,015